Tafinlar — supply status, manufacturers & alternatives

Tafinlar

—

🇦🇺 AUST R 397093 · Novartis Pharmaceuticals Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Tafinlar
Therapeutic category	Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper
Controlled substance	No
Marketing-authorisation holders	Novartis Pharmaceuticals Australia Pty Ltd, Novartis Pharmaceuticals Corporation, Novartis Europharm Limited, NOVARTIS PHARMACEUTICALS CANADA INC

Registrations on file	8

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders8 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
TAFINLAR dabrafenib	10 mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
Tafinlar	75mg/1	capsule	🇺🇸 US	Novartis Pharmaceuticals Corporation	Active
Tafinlar	50mg/1	capsule	🇺🇸 US	Novartis Pharmaceuticals Corporation	Active
Tafinlar	10mg/1	tablet	🇺🇸 US	Novartis Pharmaceuticals Corporation	Active
TAFINLAR dabrafenib	75 mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
TAFINLAR dabrafenib	50 mg	—	🇦🇺 AU	Novartis Pharmaceuticals Australia Pty Ltd	Active
Tafinlar	—	—	🌐 EU	Novartis Europharm Limited	Active
TAFINLAR	—	capsule	🇨🇦 CA	NOVARTIS PHARMACEUTICALS CANADA INC	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.